29/03/2026 06:11
|
Medical, Health & Aged Care
* About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies
* A significantly greater PASI 75 response rate...